Colin is an independent consultant and Non Executive Director, who focuses on
research and commercial activities and knowledge transfer in academic, business,
life sciences and healthcare organisations.
Until recently, Colin was the Director of Business Development at Imperial
College London. He and his team were instrumental in building Imperial’s profile
as an international exemplar of industry– academia collaboration and in increasing
its industry funded research revenue from £28m to £43m per annum.
Prior to Imperial, Colin worked in the commercial Life Sciences sector for over
twenty five years, both for pharmaceutical companies and as a management
consultant to many of the major pharmaceutical and biotechnology companies.
Before joining the College, Colin was Vice President of Cambridge Pharma
Consultancy, where he was Consulting Leader of the Commercial and R&D
Strategy Practice. He also held senior consulting and commercial roles at Ernst
& Young, IBM and PA Consulting, ICL and Eli Lilly.
Colin is a Chartered Management Consultant, a Fellow of the Institute of Business Consulting and a Fellow of the
Institute of Directors. He has a 2nd MB, BA and MA in Natural Sciences from Cambridge University and a PhD in Medical Science from London University. He has sat on numerous management and Company Boards.
